Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study
- Resource Type
- Article
- Source
- In
Heliyon June 2022 8(6) - Subject
- Language
- ISSN
- 2405-8440